Condition 1: Glaucoma is a group of disorders that differ in their pathophysiology, risk factors, manifestations, treatments, and prognoses. Their common feature is progressive degeneration of the optic nerve, with loss of retinal ganglion cells, thinning of the retinal nerve fiber layer, and progressive excavation of the optic disc. Condition 2: A cataract is a cloudy area in the lens of the eye that leads to a decrease in vision. It often develop slowly and can affect one or both eyes. Absolu
Conditions
Interventions
Intervention 1: Intervention group: First group: The first group underwent phaco-trabeculectomy (PT) surgery, in which after phycoemulsification (PE), a limbus block measuring 1×1 mm will be removed f
Sponsors
Kerman University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Glaucoma of Primary Open-Angle Glaucoma (POAG), Pseudoexfoliative Glaucoma (PXG), Chronic Angle Closure Glaucoma (CACG) uncontrolled with at least 2 topical medications (0.5% thymolol drops, 2 times a day) and dorsolamide 3 times daily (IOP > 21 mm Hg). Glaucoma of Primary Open-Angle Glaucoma (POAG), Pseudoexfoliative Glaucoma (PXG), Chronic Angle Closure Glaucoma (CACG) Despite using several anti-glaucoma drugs. Significant cataract (BCVA =20 / 60) justified by lens opacity.
Exclusion criteria
Exclusion criteria: History of intraocular surgery such as vitreous and retinal surgery Phacomorphic glaucoma Significant corneal opacity Secondary glaucoma (Uveitis Glaucoma, neovascular glaucoma, pigmentary glaucoma) Diabetic retinopathy History of eye trauma Posterior chamber eye diseases History of phycoemulsification (PE) and glaucoma surgeries Incomplete participants' information (> 10%) Signing the written informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intraocular pressure (IOP). Timepoint: At the beginning of the study (before the intervention), in the first and fourth weeks, and sixth months after surgery. Method of measurement: Goldmann tonometry.;Number of drops used to reduce IOP. Timepoint: Before intervention, 1 and 4 weeks and 6 months after intervention. Method of measurement: The designed checklist.;Intraoperative complications. Timepoint: From the beginning to the end of the surgery. Method of measurement: Examination by a glaucoma subspecialist.;Postoperative early complications. Timepoint: In 1 and 4 weeks following surgery. Method of measurement: Examination by a glaucoma subspecialist.;Postoperative late complications. Timepoint: Six months after surgery. Method of measurement: Examination by a glaucoma subspecialist.;Visual Acuity. Timepoint: Before intervention, 1 and 4 weeks and 6 months after surgery. Method of measurement: Snellen chart. | — |
Secondary
| Measure | Time frame |
|---|---|
| Need to use antiglaucoma drugs after surgery. Timepoint: In the first and fourth weeks and the sixth month after surgery. Method of measurement: Examination by a glaucoma subspecialist. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahdi Sharifzadeh Kermani
Kerman University of Medical Sciences
Outcome results
None listed